Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.

Naume, Bjørn

Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec 2014 - 3848-57 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Webcast

1527-7755

10.1200/JCO.2014.56.9327 doi


Antineoplastic Agents, Phytogenic--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bone Marrow Cells--chemistry
Breast Neoplasms--chemistry
Chemotherapy, Adjuvant
Chi-Square Distribution
Cyclophosphamide--administration & dosage
Disease-Free Survival
Docetaxel
Drug Administration Schedule
Epirubicin--administration & dosage
Female
Fluorouracil--administration & dosage
Humans
Immunohistochemistry
Infusions, Intravenous
Kaplan-Meier Estimate
Keratins--analysis
Ki-67 Antigen--analysis
Middle Aged
Neoplastic Cells, Circulating--chemistry
Norway
Predictive Value of Tests
Proportional Hazards Models
Prospective Studies
Retreatment
Risk Factors
Taxoids--administration & dosage
Time Factors
Treatment Failure